Contents 2 min read
Claim and source comparison
Phosphatidylserine: a soy-extract memory trial, an exercise-hormone trial and Health Canada's soy-product safety assessment.
· Bounded source comparison; not a complete clinical review or independent medical endorsement.
Human randomized controlled trial
Kato-Kataoka et al. (2010) assigned 78 people with memory complaints to soy-derived PS at 100 or 300 mg/day or placebo for 6 months. Test scores increased similarly in all groups, including placebo.
Within-group improvement in the low-baseline subgroup is not overall superiority to placebo. Results do not transfer to every product; some authors had institutional ties to Yakult.
Source 2 · Abstract read
Human randomized controlled trial
Starks et al. (2008) compared 600 mg/day PS with placebo for 10 days in a crossover trial in 10 men. Peak cortisol and cortisol area under the curve during moderate exercise were lower; growth hormone did not change.
This small, short hormone trial did not demonstrate memory enhancement, anxiety treatment or long-term stress control. The studied amount is not a personal daily-dose recommendation.
Source 3 · Abstract read
Official safety summary
Health Canada's assessment covers only adding soy-derived PS to foods under specified conditions. The 300 mg/day value is not a safe upper limit for every PS product or a personal-dose recommendation.
This assessment does not establish memory efficacy or safety of all formulations. People with soy allergy should check ingredient labels; choosing another plant source does not automatically eliminate allergy risk.
Source 5 · Official summary read
Correction · 2026-11-11. Soy-derived PS, exercise-hormone outcomes and the food-safety assessment were separated. General-dose, cortisol-regulation and universal product-safety statements were removed.
What is Phosphatidylserine?
Crook et al. (1991) studied bovine-brain PS at 300 mg/day for 12 weeks in 149 people with age-associated memory complaints. The result cannot be directly generalized to all soy or sunflower products or healthy young people.
Clinical Evidence
Kato-Kataoka et al. (2010) assigned 78 people with memory complaints to soy-derived PS at 100 or 300 mg/day or placebo for 6 months. Test scores increased similarly in all groups, including placebo.
Within-group improvement in the low-baseline subgroup is not overall superiority to placebo. Results do not transfer to every product; some authors had institutional ties to Yakult.
Starks et al. (2008) compared 600 mg/day PS with placebo for 10 days in a crossover trial in 10 men. Peak cortisol and cortisol area under the curve during moderate exercise were lower; growth hormone did not change.
This small, short hormone trial did not demonstrate memory enhancement, anxiety treatment or long-term stress control. The studied amount is not a personal daily-dose recommendation.
Dose information and research limits
Dose information and research limits
This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.
Safety and Side Effects
Health Canada's assessment covers only adding soy-derived PS to foods under specified conditions. The 300 mg/day value is not a safe upper limit for every PS product or a personal-dose recommendation.
This assessment does not establish memory efficacy or safety of all formulations. People with soy allergy should check ingredient labels; choosing another plant source does not automatically eliminate allergy risk.
Related research and reading
These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.
Research and safety news
- · Research
Supplement review finds mixed cognitive signals across Alzheimer’s and MCI trialsA 29-trial network review found mixed signals across cognitive tests in Alzheimer’s disease and mild cognitive impairment; no supplement significantly improved ADAS-Cog.
Sources
- Crook TH, et al. (1991). Effects of phosphatidylserine in age-associated memory impairment. Neurology, 41(5), 644–649. PubMed · PMID 2027477
- Kato-Kataoka A, et al. (2010). Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. Journal of Clinical Biochemistry and Nutrition, 47(3), 246–255. PubMed · PMID 21103034
- Starks MA, et al. (2008). The effects of phosphatidylserine on endocrine response to moderate intensity exercise. Journal of the International Society of Sports Nutrition, 5, 11. PubMed · PMID 18662395
- Glade MJ, Smith K. (2015). Phosphatidylserine and the human brain. Nutrition, 31(6), 781–786. PubMed · PMID 25933483
- Health Canada. Summary of Health Canada’s safety assessment of phosphatidylserine for use as a supplemental ingredient. https://www.canada.ca/en/health-canada/services/food-nutrition/public-involvement-partnerships/modification-list-permitted-supplemental-ingredients-enable-use-phosphatidylserine-soy/summary.html Health Canada
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
Crook et al. (1991) studied bovine-brain PS at 300 mg/day for 12 weeks in 149 people with age-associated memory complaints. The result cannot be directly generalized to all soy or sunflower products or healthy young people.
Kato-Kataoka et al. (2010) studied soy PS at 100 or 300 mg/day for 6 months in 78 people; there was no overall difference across groups, with findings in the lower-baseline subgroup. Starks et al. (2008) studied exercise cortisol in 10 men using 600 mg/day for 10 days.
Health Canada's assessment covers only adding soy-derived PS to foods under specified conditions. The 300 mg/day value is not a safe upper limit for every PS product or a personal-dose recommendation.
Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.
No established timeframe